$214 Million is the total value of Texan Capital Management's 147 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | Medtronic PLC | $1,285,000 | – | 18,038 | +100.0% | 0.60% | – | |
ABMD | New | Abiomed Inc | $982,000 | – | 8,719 | +100.0% | 0.46% | – |
SLCA | New | U.S. Silica Holdings Inc | $668,000 | – | 11,785 | +100.0% | 0.31% | – |
ABBV | New | AbbVie Inc | $512,000 | – | 8,171 | +100.0% | 0.24% | – |
FMSA | New | Fairmount Santrol Holdings Inc | $508,000 | – | 43,065 | +100.0% | 0.24% | – |
PFE | New | Pfizer Inc | $424,000 | – | 13,041 | +100.0% | 0.20% | – |
ABT | New | Abbott Laboratories | $218,000 | – | 5,671 | +100.0% | 0.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-03
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Dril-Quip Inc. | 19 | Q4 2017 | 19.6% |
Main Street Capital Corp | 19 | Q4 2017 | 4.1% |
Enterprise Prods Partners LP | 19 | Q4 2017 | 3.4% |
Exxon Mobil Corp | 19 | Q4 2017 | 2.8% |
Magellan Midstream Partners LP | 19 | Q4 2017 | 3.1% |
General Electric Co | 19 | Q4 2017 | 2.4% |
EOG Resources | 19 | Q4 2017 | 2.5% |
Bristol Myers Squibb Co | 19 | Q4 2017 | 3.1% |
Plains All Amern Pipeline | 19 | Q4 2017 | 1.9% |
Kinder Morgan Inc Del | 19 | Q4 2017 | 4.1% |
View Texan Capital Management's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2018-02-02 |
13F-HR | 2017-10-26 |
13F-HR | 2017-07-13 |
13F-HR | 2017-05-15 |
13F-HR | 2017-02-03 |
13F-HR | 2016-11-02 |
13F-HR | 2016-08-03 |
13F-HR | 2016-05-11 |
13F-HR | 2016-01-27 |
13F-HR | 2015-11-10 |
View Texan Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.